- Home
- VECO vs NVCR Comparison
VECO vs NVCR Comparison
Compare VECO & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VECO
- NVCR
- Stock Information
- Founded
- VECO 1945
- NVCR 2000
- Country
- VECO United States
- NVCR Switzerland
- Employees
- VECO N/A
- NVCR N/A
- Industry
- VECO Industrial Machinery/Components
- NVCR Medical/Dental Instruments
- Sector
- VECO Technology
- NVCR Health Care
- Exchange
- VECO Nasdaq
- NVCR Nasdaq
- Market Cap
- VECO 1.4B
- NVCR 1.4B
- IPO Year
- VECO 1994
- NVCR 2015
- Fundamental
- Price
- VECO $28.40
- NVCR $13.00
- Analyst Decision
- VECO Buy
- NVCR Buy
- Analyst Count
- VECO 6
- NVCR 7
- Target Price
- VECO $27.33
- NVCR $28.79
- AVG Volume (30 Days)
- VECO 962.3K
- NVCR 1.4M
- Earning Date
- VECO 11-05-2025
- NVCR 10-29-2025
- Dividend Yield
- VECO N/A
- NVCR N/A
- EPS Growth
- VECO N/A
- NVCR N/A
- EPS
- VECO 1.02
- NVCR N/A
- Revenue
- VECO $700,334,000.00
- NVCR $630,160,000.00
- Revenue This Year
- VECO N/A
- NVCR $6.68
- Revenue Next Year
- VECO $8.48
- NVCR $7.01
- P/E Ratio
- VECO $27.83
- NVCR N/A
- Revenue Growth
- VECO N/A
- NVCR 14.58
- 52 Week Low
- VECO $16.92
- NVCR $10.87
- 52 Week High
- VECO $34.34
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- VECO 76.07
- NVCR 56.24
- Support Level
- VECO $24.52
- NVCR $12.53
- Resistance Level
- VECO $25.96
- NVCR $13.24
- Average True Range (ATR)
- VECO 0.74
- NVCR 0.59
- MACD
- VECO 0.26
- NVCR 0.15
- Stochastic Oscillator
- VECO 94.43
- NVCR 65.82
About VECO Veeco Instruments Inc.
Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.